Bell Potter names the best ASX 200 shares to buy in FY26

The broker has good things to say about these shares.

| More on:
A group of businesspeople clapping.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

sdf

With the new financial year just days away, now could be an opportune time to think about making some new additions to your investment portfolio.

To help you narrow down your options, let's take a look at three ASX 200 shares that Bell Potter has named among its top picks for FY 2026. They are as follows:

JB Hi-Fi Ltd (ASX: JBH)

Bell Potter thinks that retail giant JB Hi-Fi could be an ASX 200 share to buy in the new financial year.

It likes the company due to its estimated 27% market share and its position as Australia's leading technology destination.

The broker believes the latter leaves its well-placed to benefit from an AI driven upgrade cycle. It advised:

We view the retailer as being able to support a higher multiple as we see a sizable upside from the AI driven upgrade cycle/replacement cycle of devices purchased during COVID-peak and given the similarities of JBH and other low gross margin yet high-earnings quality retailers globally.

Bell Potter has a buy rating and $114.00 price target on its shares.

Telix Pharmaceuticals Ltd (ASX: TLX)

Another ASX 200 share to be given the thumbs up by the broker is radiopharmaceuticals leader Telix.

It highlights that its lead product, Illuccix, continues to deliver increasing revenues as the market for PSMA PET expands and as it takes share in its key market in the United States.

Commenting on its positive view of the stock, the broker adds:

We expect average selling price will largely be preserved as the company switches most of its Medicare outpatient client base to the recently approved Gozellix format from 1 October 2025 when the refresh on the pass through pricing is expected to come to bear. Elsewhere, we anticipate the approval of Zircaix in 3Q25 for the imaging of clear cell renal cell carcinoma (ccRCC). Additional short term catalysts include interim data from the PROSTACT Global trial regarding safety and dosimetry from the 30 patient run in study.

Bell Potter has a buy rating and $34.00 price target on Telix's shares.

WiseTech Global Ltd (ASX: WTC)

Finally, this leading provider of software solutions to the global logistics services industry could be an ASX 200 share to buy in FY 2026 according to the broker.

It notes that its shares have pulled back recently due to corporate governance issues around the behaviour of founder Richard White and delays to new product launches. However, it feels the dark clouds are clearing and it will be onwards and upwards for WiseTech Global. It explains:

In our view, however, both issues will progressively fade into the background as a new board and management team are established and CTO is released in FY26. There is also a boost to revenue and earnings to come from a recently announced acquisition – e2Open – and this neatly fills any gap from the delay in launch of new products. Lastly, the stock has underperformed peers like Technology One (TNE) and Xero (XRO) and we now expect relative outperformance as the issues subside.

Bell Potter has a buy rating and $122.50 price target on its shares.

Motley Fool contributor James Mickleboro has positions in Technology One, WiseTech Global, and Xero. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Technology One, Telix Pharmaceuticals, WiseTech Global, and Xero. The Motley Fool Australia has positions in and has recommended WiseTech Global and Xero. The Motley Fool Australia has recommended Jb Hi-Fi, Technology One, and Telix Pharmaceuticals. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A mature age woman with a groovy short haircut and glasses, sits at her computer, pen in hand thinking about information she is seeing on the screen.
Broker Notes

Passive income: What's CBA's dividend outlook according to Macquarie?

Is CBA still a top passive income stock?

Read more »

A smiling woman looks at her phone as she walks with her suitcase inside an airport.
Broker Notes

Down 41% in a year, why Macquarie thinks Flight Centre shares are set to rebound

Is Flight Centre about to take off?

Read more »

A group of miners in hard hats sitting in a mine chatting on a break as ASX coal shares perform well today
Broker Notes

Does Macquarie rate Liontown Resources shares a buy, hold or sell?

Let’s find out what the broker had to say.

Read more »

Machinery at a mine site.
Broker Notes

Up 48% this year, does Macquarie think Lynas Rare Earths has further to run?

Changing market dynamics.

Read more »

A couple cheers as they sit on their lounge looking at their laptop and reading about the rising Redbubble share price
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

two men smiling with a laptop in front of them, symbolising a rising share price.
Broker Notes

These ASX 200 shares could rise 25% to 60%

Analysts think these shares are top buys and could rise materially.

Read more »

A happy young couple lie on a wooden deck using a skateboard for a pillow.
Broker Notes

Bell Potter says this growing ASX 200 stock can rise over 40%

Big returns could be on the cards for buyers of this stock.

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »